Showing 251-260 of 625 results for "".
Navigating the LGMD2I/R9 Diagnostic Pathway
https://mededonthego.com/programs/cme/navigating-the-lgmd2ir9-diagnostic-pathway/35879/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Advancing Care: Clinical Innovations on the Horizon
https://mededonthego.com/programs/cme/advancing-care-clinical-innovations-on-the-horizon/35881/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.The Role of Multidisciplinary Care in LGMD2I/R9
https://mededonthego.com/programs/cme/the-role-of-multidisciplinary-care-in-lgmd2ir9/35880/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Establishing Our Foundation of LGMD2I/R9
https://reachmd.com/programs/cme/establishing-our-foundation-of-lgmd2ir9/35588/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action
https://practicalneurology.com/programs/cme/the-science-behind-fcrn-antagonists-a-deep-dive-into-their-mechanism-of-action/32241/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid
https://practicalneurology.com/programs/cme/balancing-risk-and-benefit-traditional-mg-treatments-and-medications-to-avoid/32240/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Headache Horizons: Key Updates in Headache and Migraine Care
https://practicalneurology.com/diseases-diagnoses/headache-pain/key-updates-in-headache-and-migraine-care/35529/From gepants to GLP-1 agonists, new therapies and a shift toward early intervention may redefine migraine care and improve quality of life for people with migraine.- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31223/CPT 2007 Updates Impact Neurology PracticesThe 2007 update to the Current Procedural Terminology (CPT) manual introduces several significant changes pertinent to neurology practices, as outlined by Mary H. McDermott in Practical Neurology. While the overall modifications affecting neurology are limi
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0407-painmngmt-pdf/31193/Chronic Pain Management: Addressing Potential Bias in Clinical AssessmentsChronic pain remains a significant challenge in neurology, often complicated by the subjective nature of pain assessment. In the article "Are You Guilty of Bias When Encountering Unexplained Pain?" by Charles Argoff, MD, publi
Concussions and the National Football League
https://practicalneurology.com/diseases-diagnoses/headache-pain/concussions-and-the-national-football-league/30595/As understanding of TBI deepens, professional sports associations are responding. An update on NFL policy allows an understanding of the intersection of research and real-life practice.